Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact factor and citation metrics in phase III cancer trials

Oncotarget(2021)10.18632/oncotarget.28044Source: DataRank Database

Impact factor and citation metrics in phase III cancer trials is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.86)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Ramez Kouzy ORCID,Michael K. Rooney ORCID,Petria Thompson,Roshal R. Patel ORCID,Maddie C. Turner

Live enrichment

PubMed:34504650 PMC:PMC8416560 OpenAlex:https://openalex.org/W3196874807

NIDCR NIH HHS

Grant: R01 DE025248

NCI NIH HHS

Grant: R01 CA218148

NCI NIH HHS

Grant: R01 CA227517

NIBIB NIH HHS

Grant: R25 EB025787

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: P50 CA097007

NIDCR NIH HHS

Grant: R01 DE028290

NIDCR NIH HHS

Grant: R56 DE025248

National Institutes of Health

Grant: 5P50CA097007-07

CA: Administrative Core

National Institutes of Health

Grant: 5R01DE025248-04

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis

National Science Foundation

Grant: 1557679

QuBBD: Collaborative Research: SMART -- Spatial-Nonspatial Multidimensional Adaptive Radiotherapy Treatment

National Institutes of Health

Grant: 5R01CA218148-02

imaging Radiation-Associated Dysphagia (iRAD)

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 1R25EB025787-01

Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)

National Institutes of Health

Grant: 3R01DE028290-02S1

Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device

National Institutes of Health

Grant: 5R01CA227517-04

Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer

FWCI

0.86

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.oncotarget.com/article/28044/pdf/

GOLDhttps://www.oncotarget.com/article/28044/pdf/

publisherhttps://www.oncotarget.com/article/28044/pdf/

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28044

journalhttps://doi.org/10.18632/oncotarget.28044

Fields of Study

Meta-analysis and systematic reviewsscientometrics and bibliometrics researchDelphi Technique in ResearchMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineClinical trialClinical endpointImpact factorCancerInternal medicineCitationSurrogate endpointOncologyLibrary scienceIndustryClinical TrialsJournal Impact FactorFdaResearch Paper

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being